Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Medulloblastoma × Digoxin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma, Synovial 1 Sarcoma, Alveolar Soft Part 1 Sarcoma 1 Pancreatic Neoplasms 1 Medulloblastoma 1 Leiomyosarcoma 1

Interventions

Temozolomide 6 Cyclophosphamide 6 Etoposide 5 Vincristine 3 Radiotherapy 3 Cisplatin 3 lutetium Lu 177 dotatate 2 etoposide phosphate 2 Radiation 2 Filgrastim 2 Celecoxib 2 Carboplatin 2 sodium thiosulfate 1 ribociclib 1 pegfilgrastim 1 palbociclib 1 olaparib 1 ibrutinib 1 fludarabine 1 fenofibric acid 1 abemaciclib 1 Topotecan 1 Thiotepa 1 Thalidomide 1 Tamoxifen 1 Tablets 1 Standard of Care 1 Specimen Handling 1 Platinum 1 ONC206 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06701812 2026-02-27

Digoxin Medulloblastoma Study

H. Lee Moffitt Cancer Center and Research Institute

Phase 2 Recruiting

Medulloblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡